InvestorsHub Logo
Followers 20
Posts 5392
Boards Moderated 0
Alias Born 01/04/2012

Re: RallyTheMarket post# 94

Saturday, 08/03/2013 8:18:28 AM

Saturday, August 03, 2013 8:18:28 AM

Post# of 14983
R3D, it is true nothing may ever materialize. But if Libigel in fact becomes a home run (CV benefits, HSDD, etc..) and they have tried to bury it or off load it cheaply to line their own pockets,I believe I have laid out a compelling start to a criminal investigation. It would give police the reasonable and probable grounds to obtain the search warrants they need to support charges. It will help formulate their line of questioning and a identify a number of people they will most likely want to interview.

Much of the so called grasping, has also been sort of a warning to management to think twice, if they think they can get away with it. I, as many of us just won't disappear into the night. I mean Simes even called me a couple of times to to get me to vote for the merger. Knowing I would post it. They were reading the BPAX board's comments. I know he was using me, but he also knew my intentions, he knows that as a police officer I was building a case, not in an official capacity, yet. I still am. I believe (now, this may be grasping) that I won't have to use it.

Most times, when investors get defrauded, police have to build a case from scratch. It is time consuming trying to put all the pieces of the puzzle together in a chronological order. Not all cases get investigated due to sheer volume. They must prioritize cases on the likelihood of success. The better the chances of solving the case the more likely they are to bump up the investigation. I am trying to increase their chances of success and raise the profile of our case should we ever have to resort to it. Management of Big Pharma is not worried about litigation and eventually settling is part of doing business. On the other hand, the possibility of serving time in prison is not part of doing business for them.

The fact the CV benefits were never clearly stated in public nor expanded upon, especially when the company was facing an R/S due to share price listing requirements, as an investigator, is a big red flag and leads me to believe there is something else at play. The patent was filed in July 2011 claiming a 71% reduction in CV events over placebo. This patent claims it was an accidental discovery

[0025] The invention is predicated, in part, upon the unexpected findings from a US-based, multi-center, randomized, placebo-controlled Phase 3 clinical trial, where the administration of a precise amount of testosterone in a transdermal formulation to postmenopausal women at high risk for cardiovascular events reduced the number of cardiovascular events compared to the expected number of cardiovascular events for an untreated postmenopausal woman. The findings indicate an unanticipated lower than expected cardiovascular event rate in postmenopausal woman using testosterone for the treatment of cardiovascular events.



Why hold back such important information and let your name become mud? Simes was nominated as one of the Worst CEOs. His reputation has taken a beating yet he sat on the above info. It just doesn't add up.

For the time being, I am giving Przybyl the benefit of the doubt and will allow him to execute his strategy, on the possibility that there is a master plan in play, beyond the simple acquisition of Biosante's cash. And, I will continue to dig to find the motive behind what we have experienced over the last two years.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ANIP News